Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
TTAX01 / BioTissue
NCT04176120: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)	Completed	3	220	US	TTAX01, Standard Care	Tissue Tech Inc.	Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer	01/24	06/24
NCT04450693: Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)	Recruiting	3	220	US	TTAX01, Standard care	Tissue Tech Inc.	Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer	09/24	09/24
TTAX03 / BioTissue
NCT05079035: Lyophilized and Micronized Particulate Human Amniotic and Umbilical Cord (TTAX03) for KL Grade 3-4 Knee OA	Active, not recruiting	2	90	US	TTAX03, Saline	Tissue Tech Inc.	Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis	07/24	03/25
NCT06236308: TTAX03 for the Treatment of Lumbosacral Facet Joint Pain	Not yet recruiting	1	36	NA	TTAX03 10mg, TTAX03 25mg, Placebo Comparator: Control Saline	Tissue Tech Inc.	Facet Joint Pain	01/25	11/25